These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 30260408)
21. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone. Sijanovic S; Karner I Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925 [TBL] [Abstract][Full Text] [Related]
22. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma. Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189 [TBL] [Abstract][Full Text] [Related]
23. High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women. Hwangbo Y; Kim JH; Kim SW; Park YJ; Park DJ; Kim SY; Shin CS; Cho NH Osteoporos Int; 2016 Feb; 27(2):457-62. PubMed ID: 26252978 [TBL] [Abstract][Full Text] [Related]
24. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women. Ongphiphadhanakul B; Puavilai G; Rajatanavin R J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984 [TBL] [Abstract][Full Text] [Related]
25. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women. Chao AS; Chen FP; Lin YC; Huang TS; Fan CM; Yu YW Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992 [TBL] [Abstract][Full Text] [Related]
26. Computed radiographic absorptiometry and morphometry in the assessment of postmenopausal bone loss. Adami S; Zamberlan N; Gatti D; Zanfisi C; Braga V; Broggini M; Rossini M Osteoporos Int; 1996; 6(1):8-13. PubMed ID: 8845604 [TBL] [Abstract][Full Text] [Related]
27. Bone mineral density referral for dual-energy X-ray absorptiometry using quantitative ultrasound as a prescreening tool in postmenopausal women from the general population: a cost-effectiveness analysis. Marín F; López-Bastida J; Díez-Pérez A; Sacristán JA; Calcif Tissue Int; 2004 Mar; 74(3):277-83. PubMed ID: 14708042 [TBL] [Abstract][Full Text] [Related]
28. Possible limited bone loss with suppressive thyroxine therapy is unlikely to have clinical relevance. Müller CG; Bayley TA; Harrison JE; Tsang R Thyroid; 1995 Apr; 5(2):81-7. PubMed ID: 7647577 [TBL] [Abstract][Full Text] [Related]
29. The effects of thyrotropin-suppressing therapy on bone metabolism in patients with well-differentiated thyroid carcinoma. Kim MK; Yun KJ; Kim MH; Lim DJ; Kwon HS; Song KH; Kang MI; Baek KH Bone; 2015 Feb; 71():101-5. PubMed ID: 25445448 [TBL] [Abstract][Full Text] [Related]
30. The relationship between thyroid function and bone mineral density in euthyroid healthy subjects in Taiwan. Lin JD; Pei D; Hsia TL; Wu CZ; Wang K; Chang YL; Hsu CH; Chen YL; Chen KW; Tang SH Endocr Res; 2011; 36(1):1-8. PubMed ID: 21226562 [TBL] [Abstract][Full Text] [Related]
31. Impact of spinal degenerative changes on the evaluation of bone mineral density with dual energy X-ray absorptiometry (DXA). Rand T; Seidl G; Kainberger F; Resch A; Hittmair K; Schneider B; Glüer CC; Imhof H Calcif Tissue Int; 1997 May; 60(5):430-3. PubMed ID: 9115160 [TBL] [Abstract][Full Text] [Related]
32. Global skeletal uptake of technetium-99m methylene diphosphonate in female patients receiving suppressive doses of L-thyroxine for differentiated thyroid cancer. Frusciante V; Carnevale V; Scillitani A; Zingrillo M; Dicembrino F; Giannatempo GM; Ghiggi MR; Minisola S Eur J Nucl Med; 1998 Feb; 25(2):139-43. PubMed ID: 9473261 [TBL] [Abstract][Full Text] [Related]
33. Bone Mineral Density Assessment in Pre- and Postmenopausal Women: Comparison Between T-Scores by Heel QUS and DXA in HRPZII. Zaini WM; Md Ariff A Med J Malaysia; 2012 Oct; 67(5):487-90. PubMed ID: 23770864 [TBL] [Abstract][Full Text] [Related]
34. Bone mineral density in postmenopausal women treated with L-thyroxine. Adlin EV; Maurer AH; Marks AD; Channick BJ Am J Med; 1991 Mar; 90(3):360-6. PubMed ID: 2003518 [TBL] [Abstract][Full Text] [Related]
35. Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women. Lehmke J; Bogner U; Felsenberg D; Peters H; Schleusener H Clin Endocrinol (Oxf); 1992 May; 36(5):511-7. PubMed ID: 1617803 [TBL] [Abstract][Full Text] [Related]
36. Bone Density Screening in Postmenopausal Women With Early-Stage Breast Cancer Treated With Aromatase Inhibitors. Stratton J; Hu X; Soulos PR; Davidoff AJ; Pusztai L; Gross CP; Mougalian SS J Oncol Pract; 2017 May; 13(5):e505-e515. PubMed ID: 28267392 [TBL] [Abstract][Full Text] [Related]
37. Spinal bone mineral assessment in postmenopausal women: a comparison between dual X-ray absorptiometry and quantitative computed tomography. Yu W; Glüer CC; Grampp S; Jergas M; Fuerst T; Wu CY; Lu Y; Fan B; Genant HK Osteoporos Int; 1995; 5(6):433-9. PubMed ID: 8695964 [TBL] [Abstract][Full Text] [Related]
38. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population. Han W; Bai X; Wang N; Han L; Sun X; Chen X Arch Osteoporos; 2017 Dec; 12(1):50. PubMed ID: 28527105 [TBL] [Abstract][Full Text] [Related]
39. The association between serum thyrotropin (TSH) levels and bone mineral density in healthy euthyroid men. Kim BJ; Lee SH; Bae SJ; Kim HK; Choe JW; Kim HY; Koh JM; Kim GS Clin Endocrinol (Oxf); 2010 Sep; 73(3):396-403. PubMed ID: 20455884 [TBL] [Abstract][Full Text] [Related]
40. The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma. Heemstra KA; Hamdy NA; Romijn JA; Smit JW Thyroid; 2006 Jun; 16(6):583-91. PubMed ID: 16839260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]